Many translated example sentences containing “eritropoyetina recombinante” – English-Spanish dictionary and search engine for English translations. La farmacocinética de la eritropoyetina recombinante humana en pacientes con nefropatía endémica de los Balcanes. The Pharmacokinetics of Recombinant. Efecto del tratamiento con eritropoyetina recombinante humana sobre la necesidad de transfusión sanguínea en los pacientes críticos. Effect of human.
|Published (Last):||24 January 2013|
|PDF File Size:||5.84 Mb|
|ePub File Size:||11.85 Mb|
|Price:||Free* [*Free Regsitration Required]|
Subscribe to receive email notifications whenever new articles are published. CiteScore measures average citations received per document published. To view content sources and attributions, please refer to our editorial policy.
Eritropoyetina recombinante humana en la insuficiencia renal crónica
Population pharmacokinetics of darbepoetin alfa in healthy subjects. Are you a health professional able to prescribe or dispense drugs? The predose plasma level of erythropoietin Epo was subtracted from all postdose levels.
J Clin Pharmacol ; Effect of human recombinant erythropoietin treatment on the need for blood transfusion in critically-ill patients. Comparison of the pharmacokinetics of beta-erythropoietin given subcutaneously to hemodialysis patients with BEN or other kidney diseases non-BEN. J Biol Chem ; We comply with the HONcode standard for trustworthy health information – verify here.
Continuing navigation will be considered as acceptance of this use.
Venous blood was collected ercombinante heparinized tubes before and at 2, 6, 8, 12, 24, 48, and 72 only in five patients h after beta-Epo administration. SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field. SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.
Eritropoyetina Humana Recombinante Delta –
Therefore, not only the distribution by itself, but also the process of elimination and interaction directly with the Epo receptor on the red blood cell surface play an important role in increasing the values of Vd for Epo in comparison to its physiological eriteopoyetina limited to extravascular space in the body.
Pharmacokinetics For pharmacokinetic analysis the predose plasma level of Epo was subtracted from all postdose levels of Epo for each patient. The relevant pharmacokinetic parameters were calculated after noncompartmental pharmacokinetic analysis using Kinetica software Thermo Scientific, ver.
Methods Study design and patients The prospective clinical study was performed according to good clinical practice and in accordance with the Declaration of Helsinki in three clinical centers. Main characteristics of the patients ACEI: Pharmacokinetic analysis of subcutaneous erythropoietin administration with nonlinear mixed effect model including endogenous production. CiteScore measures average citations received per document published.
Renal function, protein excretion and pathology of Balkan endemic nephropathy. The Journal publishes articles on basic or clinical research relating to nephrology, arterial hypertension, dialysis and kidney transplants. Eritropoyetiha serum creatinine and PTH concentrations were significantly lower, and serum calcium concentration was significantly higher in the BEN than in the non-BEN group.
There was a problem providing the content you requested
Pavlovic-Kentera V, Djukanovic Lj. Show all Show less.
J Clin Pharmacol The enigma of the metabolic fate of circulating erythropoietin Epo in view of recombinanfe pharmacokinetics of the recombinant drugs rhEpo and NESP. J Am Soc Nephrol ; SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal’s impact.
No significant differences between groups were found in maximal Epo concentration, time to maximum Epo concentration, area under the curve from time of dosing extrapolated to infinity, clearance, mean residence time of Epo between groups both before and after adjustment.
After beta-Epo administration plasma Epo slowly increased and C max was achieved after Investigation of the effects of altered receptor binding activity on the clearance of erythropoiesis-stimulating proteins: The pharmacokinetic parameters of Epo are presented in Table 3. Causas de respuesta ineficaz a la eritropoyetina recombinante.
As previous studies showed that the kidneys contribute to Epo elimination in a very minor fashion 35 and residual kidney function in patients more than three years on dialysis is most often negligible, it is not expected that renal elimination of Epo could be of any influence.
The main limitation of our study was the small number of patients in each group, and they eritropoywtina not matched in age.
The prospective clinical study was performed according to good clinical practice and in accordance with the Declaration of Helsinki in three clinical centers. SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field. Clin J Am Soc Nephrol ;3: Erythropoietin Epo concentration was determined in all samples on the same day by chemiluminescent immunoassay for erythropoietin on an Immulite analyzer Siemens Healthcare Diagnostics.
Continuing navigation will be considered as acceptance of this use. Are you a health professional able to prescribe or dispense drugs? Population pharmacokinetics and pharmacodynamics of peptidic erythropoiesis receptor agonist ERA in healthy volunteers.
The dose eritropoyerina beta-Epo was adjusted to attain the recombinatne target range defined by European best practice guidelines for the management of recombinannte in patients eritropyetina chronic renal failure The journal fully endorses the goals of updating knowledge and facilitating the acquisition of key developments in internal medicine applied to clinical practice. Nephrol Dial Transplant ;19 Suppl 2: Endemic Balkan Nephropathy, Proc. Continuing navigation will be considered as acceptance of this use.
Pharmacokinetic and pharmacodynamic profiles of extended dosing of epoetin alfa in anemic patients who have chronic kidney disease and are not on dialysis.